You are here: Home » International » News » Companies
Japan's ANA airline secures $3.8 bn loan as Covid-19 travel slump bites
Business Standard

Eli Lilly to continue other Covid-19 antibody drug trials after pausing one

Lilly said the government-sponsored clinical trial of its Covid-19 antibody treatment, which is similar to one taken by U.S. President Donald Trump, had been paused over safety concerns.

Topics
Eli Lilly | Coronavirus Vaccine

Reuters 



Eli Lilly logo is shown on one of the company's offices in San Diego, California. Photo: Reuters
Eli Lilly logo is shown on one of the company's offices in San Diego, California. Photo: Reuters

& Co on Wednesday said that other trials of its experimental Covid-19 antibody drug will continue apace after it paused one ongoing trial of the drug, citing safety concerns.

TO READ THE FULL STORY, SUBSCRIBE NOW NOW AT JUST RS 249 A MONTH.

SUBSCRIBE TO INSIGHTS

What you get on Business Standard Premium?

  • icon Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • icon Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • icon Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
  • icon Pick your 5 favourite companies, get a daily email with all news updates on them.
  • icon 26 years of website archives.
  • icon Preferential invites to Business Standard events.

OR


Subscribe to Business Standard Premium

Exclusive Stories, Curated Newsletters, 26 years of Archives, E-paper, and more!

Insightful news, sharp views, newsletters, e-paper, and more! Unlock incisive commentary only on Business Standard.

Download the Business Standard App for latest Business News and Market News .

First Published: Wed, October 14 2020. 20:30 IST

RECOMMENDED FOR YOU

.